財報
China Resources Pharmaceutical Group (03320.HK): Kunming Pharmaceutical Group forecasts a net loss attributable to shareholders of RMB 330 million to RMB 400 million for the first half of the year, swinging from profit to loss
Kunming Pharmaceutical Group, part of China Resources Pharmaceutical, forecast a first-half net loss of RMB 330-400 million, swinging from a prior-year profit.
大盤 開啟原文 ↗